Zydus Lifesciences gets USFDA nod to market Scopolamine transdermal system

Zydus Lifesciences Ltd has received USFDA approval to market its Scopolamine transdermal system, which helps prevent nausea and vomiting under various conditions, including after surgery and due to motion sickness. The product, with a dosage of 1 mg/3 days, will be manufactured in Ahmedabad.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kSlFUcB
via IFTTT